ASTRAZENECA AB TRADE DATA ANALYSIS
Access comprehensive trade data for Astrazeneca Ab with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Astrazeneca Ab – Overview
Eximpedia analyzes Astrazeneca Ab export and import records, including data from 0 buyers and 1 suppliers. We provide an intelligence report of Astrazeneca Ab that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
Astrazeneca Ab Buyers, Suppliers & Shipments
Astrazeneca Ab import markets
Explore the Astrazeneca Ab import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3004900000 | 30.43 | 478 | 66.76 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004320000 | 24.09 | 143 | 19.97 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004390000 | 8.65 | 95 | 13.27 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| SWEDEN | 33.62 | 281 | 39.25 |
| UNITED STATES | 16.79 | 169 | 23.60 |
| GREAT BRITAIN | 8.51 | 59 | 8.24 |
| PUERTO RICO | 3.75 | 76 | 10.61 |
| GERMANY | 0.31 | 84 | 11.73 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UA100200 | 63.17 | 716 | 100.00 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| MINISTRY OF HEALTH | 206.51 | 8344 |
| SOCIAL SECURITY INSTITUTION | 231.08 | 35 |
| BADM LIMITED LIABILITY COMPANY | 394.73 | 5166 |
| JV OPTIMA FARM LIMITED | 400.43 | 5786 |
| TURKISH PHARMACISTS ASSOCIATION ECONOMIC ENTERPRISE | 536.15 | 2196 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| TANNER PHARMA CH GMBH ON BEHALF OF MAXAID | 117.29 | 15 |
| BIOGEN INTERNATIONAL GMBH | 127.48 | 115 |
| BOEHRINGER INGELHEIM | 146.49 | 839 |
| BMED INTERNATIONAL BUSINESS COMPANY LIMITED | 150.27 | 163 |
| GEN ILAÇ INTERNATIONAL TRADING LIMITED | 244.44 | 236 |
If you are looking to establish relationship with Astrazeneca Ab Automation you can save time by getting access to the key decision makers and get a detailed report.
Astrazeneca Ab Import Shipments
Discover the Astrazeneca Ab with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 3004320000 | 1. MEDICINAL PRODUCTS FOR HUMAN USE, FOR THERAPEUTIC USE, PACKAGED FOR RETAIL (CONTAINING CORTICOSTEROID HORMONES), NOT IN AEROSOLS PACKAGING. PULMICORT SPRAY SUSPENSION, 0.25 MG/ML; 2 ML IN A CONTAINER; 5 CONTAINERS IN AN ENVELOPE; 4 ENVELOPES IN A CARTON/1 ML OF SPRAY SUSPENSION CONTAINS 0.25 MG BUDESONIDE/ASTRAZENECA AB (MANUFACTURING, QUALITY CONTROL AND BATCH RELEASE; QUALITY CONTROL ), SWEDEN PULMICORT TURBUCHALER POWDER FOR INHALATION , 100 MCG/DOSE OF 200 DOSES IN A PLASTIC INHALER , 1 INHALER IN A CARTON / 1 DOSE (INHALING) CONTAINS 100 MCG BUDESONIDE/ ASTRAZENECA AB (MANUFACTURING, FILLING, QUALITY CONTROL, LABELING, SECONDARY PACKAGING AND BATCH RELEASE), SWEDEN BUDESONIDE SUSP ENZIA FOR SPRAYING, 0.5 MG/ML PO 2 ML IN CONTAINER; 5 CONTAINERS EACH, IN AN ENVELOPE; 4 ENVELOPES IN A CARDBOARD BOX/1 ML OF SPRAY SUSPENSION CONTAINING 0.5 MG OF BUDESONIDE/ASTRAZENECA AB (MANUFACTURING, QUALITY CONTROL AND BATCH RELEASE), SWEDISH SYMBICORT TURBUCHALER POWDER FOR INHALATION, DOSED, 80 M KG/4.5 MCG/DOSE; 60 DOSES IN A PLASTIC INHALER; 1 INHALER IN A CARTON/1 INHALATION (1 DOSE) CONTAINS: 80 MCG OF MICRONIZED BUDESONIDE; 4.5 MCG FORMOTEROL FUMARATE DIHYDRATE/ASTRAZENECA AB (MANUFACTURING, QUALITY CONTROL AND BATCH RELEASE), SWEDENSYMBICORT TURBUCHALER INHALATION POWDER, DOSED, 160 MCG/4.5 MCG/DOSE; 60 DOSES IN A PLASTIC INHALER; 1 INHALER IN A CARTON BOX/1 INHALATION (1 DOSE) CONTAINS: 160 MCG OF MICRONIZED BUDESONIDE; 4.5 MCG FORMOTEROL FUMARATE DIHYDRATE/ASTRAZENECA AB (MANUFACTURING, QUALITY CONTROL AND BATCH RELEASE), SWEDENSYMBICORT TURBUCHALER INHALATION POWDER, DOSED, 320 MCG/9.0 MCG/DOSE; 60 DOSES IN A PLASTIC INHALER; 1 INHALER IN A CARTON BOX/1 INHALATION (1 DOSE) CONTAINS: 320 MCG OF MICRONIZED BUDESONIDE; 9.0 MCG FORMOTEROL FUMARATE DIHYDRATE/ASTRAZENECA AB (MANUFACTURING, QUALITY CONTROL AND BATCH RELEASE), SWEDEN |  |
|
SWEDEN | UKRAINE | 0 |
| 3004900000 | 1. HUMAN MEDICINES FOR THERAPEUTIC USE, PACKAGED FOR RETAIL TRADE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. BETALOK ZOK TABLETS , COVERED WITH A FILM COVER, WITH A SLOW RELEASE OF 100 MG; 30 TABLETS IN A VIAL; 1 VIAL IN A CARTON/1 TABLET CONTAINS 95 MG OF METOPROL SUCCINATE, EQUIVALENT TO 100 MG OF METOPROL TARTRATE/ASTRAZENECA AB (MANUFACTURING, PACKAGING, QUALITY CONTROL AND ISSUANCE OF THE FINISHED MEDICINAL PRODUCT BATCH). BU), SWEDEN | |
|
SWEDEN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMAN USE, PACKAGED FOR RETAIL TRADE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING 'EKTSIJ, 1 MG/ML; 5 ML IN AN AMPOULE; 5 AMPOULES IN A CARTON/1 ML SOLUTION FOR INJECTION CONTAINING METOPROLOL TARTRATE 1 MG/SENEXI, FRANCE | |
|
FRANCE | UKRAINE | 0 |
| 3004900000 | 1. MEDICINES FOR HUMAN USE, PACKAGED FOR RETAIL TRADE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. KRESTOR TABLETS, INCL ITI WITH THE MEMBRANE, 10 MG, PO 14 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINING 10 MG OF ROSUVASTATIN IN THE APPEARANCE OF 10.40 MG OF ROSUVASTATIN CALCIUM / IPIER PHARMACEUTICALS INC. (MANUFACTURER OF MEDICINE IN BULK), PUERTO RICO, USA | |
|
PUERTO RICO | UKRAINE | 0 |
| 3004320000 | 1. MEDICINES FOR HUMANS CONTAINING CORTICOSTEROID HORMONES, PACKAGED FOR RETAIL, NOT IN AEROSOLS: ASTRAZENECA BUDESONIDE, SPRAY SUSPENSION, 0.25 MG/ML, 2 ML CONTAINER; 5 CONTAINERS IN AN ENVELOPE; 4 ENVELOPES IN A CARDBOARD BOX / 1 ML OF SPRAY SUSPENSION CONTAINS 0.25 MG OF BUDESONIDE; MANUFACTURER ASTRAZENECA AB (MANUFACTURING, QUALITY CONTROL AND BATCH RELEASE), SWEDEN; ASTRAZENECA SPRAY SUSPENSION ENNA, 0.5 MG/ML PER 2 ML IN CONTAINER; 5 CONTAINERS EACH, IN AN ENVELOPE; 4 ENVELOPES IN A CARDBOARD BOX / 1 ML OF SPRAY SUSPENSION CONTAINS 0.5 MG OF BUDESONIDE; MANUFACTURER ASTRAZENECA AB (MANUFACTURING, QUALITY CONTROL AND BATCH RELEASE), SWEDEN; SYMBIKORT TURBUHALER, INHALATION POWDER, D OZOVANY, PO 80 МКГ/4.5 ICG/DOSE, 60 DOSES IN A PLASTIC INHALER; 1 INHALER IN A CARDBOARD BOX / 1 INHALATION (1 DOSE) CONTAINS: 80 MCG OF MICRONIZED BUDESONIDE; 4.5 MKG OF FORMOTEROL FUMARATE DIHYDRATE; MANUFACTURER, FILLING, QUALITY CONTROL, LABELING, SECONDARY PACKAGING AND BATCH RELEASE), SWEDEN; SYMBICORT TURBUCHALER, POWDER FOR INHALATION, DOSED, PO 160 ICG/4.5 ICG/DOSE, 60 DOSES IN A PLASTIC INHALER; 1 INHALER IN A CARDBOARD BOX / 1 INHALATION (1 DOSE) CONTAINS: 160 MCG OF MICRONIZED BUDESONIDE; 4.5 MKG OF FORMOTEROL FUMARATE DIHYDRATE; MANUFACTURER, FILLING, QUALITY CONTROL, LABELING, SECONDARY PACKAGING AND BATCH RELEASE), SWEDEN; SYMBICORT TURBUCHALER, POWDER FOR INHALATION, DOSED, PO 320 ICG/9.0 ICG/DOSE, 60 DOSES IN A PLASTIC INHALER; 1 INHALER IN A CARDBOARD BOX / 1 INHALATION (1 DOSE) CONTAINS: 320 MCG OF MICRONIZED BUDESONIDE; 9 MCG FORMOTEROL FUMARATE DIHYDRATE; MANUFACTURED BY ASTRAZENECA AB (MANUFACTURING, FILLING, QUALITY CONTROL, LABELING, SECONDARY PACKAGING AND BATCH RELEASE), SWEDEN | |
|
SWEDEN | UKRAINE | 0 |
| 3004320000 | 1. MEDICINES FOR HUMANS CONTAINING CORTICOSTEROID HORMONES, PACKAGED FOR RETAIL SALE, NOT IN AEROSOLS: PULMICORT TURBUCHALER, POWDER FOR INHALATION, 100 MCG/DOSE 200 DOSE IN PLASTIC INHALER, 1 INHALER IN A CARDBOARD BOX / 1 DOSE (INHALING ) CONTAINS 100 MCG OF BUDESONIDE; MANUFACTURED BY ASTRAZENECA AB (MANUFACTURING, FILLING, QUALITY CONTROL, LABELING, SECONDARY PACKAGING AND BATCH RELEASE), SWEDEN; PULMICORT TURBUCHALER, INHALATION POWDER, 200 MCG/DOSE OZ IN A PLASTIC INHALER, PER 1 INHALER V CARTON / 1 DOSE (INHALING) CONTAINS 200 MCG BUDESONIDE; MANUFACTURER ASTRAZENECA AB (MANUFACTURING, FILLING, QUALITY CONTROL, SECONDARY PACKAGING AND BATCH RELEASE), SWEDEN; PULMICORT, SPRAY SUSPENSION, 0.5 MG/ML PO 2 ML IN CONTAINER; 5 CONTAINERS IN AN ENVELOPE; 4 ENVELOPES IN A CARDBOARD BOX / 1 ML OF SPRAY SUSPENSION CONTAINS 0.5 MG BUDESONIDE; MANUFACTURED BY ASTRAZENECA AB (MANUFACTURING, QUALITY CONTROL AND BATCH RELEASE; QUALITY CONTROL), SWEDEN | |
|
SWEDEN | UKRAINE | 0 |
| 3004390000 | 1. DRUGS FOR HUMANS CONTAINING HORMONES, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ZOLADEX, SUBCUTANEOUS 10.8 MG LONG-RELEASE CAPSULE, 1 CAPSULE IN SYRINGE-APPLICATOR WITH PROTECTIVE MECHANISM; 1 SYRINGE IN AN ENVELOPE WITH AN ATTACHED ANNOTATION FLAG WITH A MOISTURE-ABSORBING CAPSULE; 1 ENVELOPE IN A CARTON / 1 CAPSULE FOR SUBCUTANEOUS ADMINISTRATION CONTAINS GOSERELIN ACETATE EQUIVALENT TO 10.8 MG GOSERELIN-BASE; MANUFACTURED BY ASTRAZENECA UK LIMITED, GREAT BRITAIN; ZOLADEX, CAPSULE FOR SUBSTANCE CUTANEOUS ADMINISTRATION OF PROLONGED EFFECT OF 3.6 MG, 1 CAPSULE IN SYRINGE APPLICATOR WITH PROTECTIVE MECHANISM; 1 SYRINGE IN AN ENVELOPE WITH AN ATTACHED ANNOTATION FLAG WITH A MOISTURE-ABSORBING CAPSULE; 1 ENVELOPE IN A CARDBOARD BOX / 1 SUBCUTANEOUS EXTENDED-RELEASE CAPSULE CONTAINS GOSERELIN ACETATE EQUIVALENT TO 3.6 MG GOSERELIN BASE; MANUFACTURED BY ASTRAZENECA UK LIMITED, GREAT BRITAIN | |
|
GREAT BRITAIN | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENTS: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: BETALOK ZOC, FILM-COATED TABLETS WITH SLOW RELEASE OF 25 MG, 14 TABLETS IN BLISTERS; 1 BLISTER IN A CARDBOARD BOX / 1 TABLET CONTAINS: 23.75 MG METOPROLO SUCCINATE EQUIVALENT TO 25 MG METOPROLO TARTRATE; MANUFACTURER ASTRAZENECA AB (MANUFACTURING, PACKAGING, QUALITY CONTROL AND ISSUANCE OF THE READY BATCH OF THAT MEDICINE), SWEDEN; BRILINT, TABLETS, COATED FILM-COATED, 90 MG; 14 TABLETS IN BLISTERS; 4 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINING 90 MG OF TICAGRELOR; MANUFACTURER ASTRAZENECA AB (MANUFACTURING OF TABLETS, TESTING, PACKAGING OF MEDICINE, BATCH RELEASE), SWEDEN; BRILINTA, FILM-COATED TABLETS, 60 MG; 14 TABLETS IN BLISTERS; 4 BLISTERS IN A CARDBOARD BOX / 1 TABLET COVERED WITH A FILM SHEATH CONTAINS 60 MG OF TIKAGRELOR; MANUFACTURER OF ASTRAZENNEK AB (PRODUCTION OF TABLETS, TESTING, PACKAGING OF MEDICINAL PRODUCT, PRODUCTION OF SERIES), SWEDEN | |
|
SWEDEN | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENTS: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ARIMIDEX, FILM-COATED TABLETS, 1 MG OF 14 TABLETS IN A BLISTER; 2 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINING 1 MG OF ANASTROSE; MANUFACTURER ASTRAZENECA PHARMACEUTICALS LP (MANUFACTURER OF MEDICINE ""IN BULK""), USA/ASTRAZENECA UK LIMITED (MANUFACTURER, RESP ALLY FOR PACKAGING AND RELEASE OF THE SERIES) , UNITED KINGDOM; COMBOGLYZA XR, FILM-COATED TABLETS, 5 MG/1000 MG 7 TABLETS IN BLISTERS; 4 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 5.58 MG SAXAGLIPTIN HYDROCHLORIDE EQUIVALENT TO SAXAGLIPTIN 5 MG AND 1005 MG METFORMIN HYDROCHLORIDE EQUIVALENT METFORMIN 1000 MG; MANUFACTURER ASTRAZENECA PHARMACEUTICALS LP, USA; KSIGDUO PROLONG, 5/1000 MG FILM-COATED TABLETS OF PROLONGED EFFECT; 7 TABLETS IN BLISTERS; 4 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS DAPAGLIFLOSIN PROPANEDIOL 6.15 MG EQUIVALENT TO 5 MG DAPAGLIFLOSIN AND METFORMIN HYDROCHLORIDE 1005.04 MG MANUFACTURER ASTRAZENECA PHARMACEUTICALS LP (IN-BULK PRODUCTION, QUALITY CONTROL, PRIMARY AND SECONDARY PACKAGING, SERIES RELEASE), USA/BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY (MANUFACTURING IN-BULK), USA; XIGDUO PROLONG, FILM-COATED TABLETS, PROLONGED-RELEASE 10/1000 MG; 7 TABLETS IN BLISTERS; 4 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS DAPAGLIFLOSIN PROPANEDIOL 12.30 MG EQUIVALENT TO 10 MG DAPAGLIFLOSIN AND METFORMIN HYDROCHLORIDE 1005.04 MG; MANUFACTURER ASTRAZENECA PHARMACEUTICALS LP (IN-BULK PRODUCTION, QUALITY CONTROL, PRIMARY AND SECONDARY PACKAGING, SERIES RELEASE), USA/ BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY (MANUFACTURING IN-BULK), USA; ANGLISA, FILM-COATED TABLETS, 5 MG, 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINING 5 MG OF SAXAGLIPTIN HYDROCHLORIDE CALCULATED AS SAXAGLIPTIN; MANUFACTURER ASTRAZENECA PHARMACEUTICALS LP (MANUFACTURER), USA/ ASTRAZENECA AB ( QUALITY CONTROL), SWEDEN/ ASTRAZENECA UK LIMITED (PACKAGING, RELEASE SERIES), UNITED KINGDOM; SEROQUEL XR, FILM-COATED TABLETS, EXTENDED RELEASE, 50 MG, 10 TABLETS IN BLISTERS; 6 BLISTERS IN A CARTON / 1 TABLET CONTAINS 57.56 MG QUETIAPINE FUMARATE EQUIVALENT TO 50 MG QUETIAPINE; MANUFACTURER ASTRAZENECA UK LIMITED (BATCH MANUFACTURER), GREAT BRITAIN /ASTRAZENECA PHARMACEUTICALS LP (MANUFACTURER IN BULK), USA; FORXIGA, FILM-COATED TABLETS, 10 MG, 10 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS 12.30 MG OF DAPAGLIFLOSIN PROPANEDIOL MONOHYDRATE AS DAPAG LIFLOSIN 10 MG; MANUFACTURER ASTRAZENECA AB (DRUG TESTING ZASOBU), SWEDEN/ ASTRAZENECA PHARMACEUTICALS LP (MANUFACTURER OF UNPACKAGED PRODUCT), USA/ ASTRAZENECA UK LIMITED (PRIMARY AND SECONDARY PACKAGING AND BATCH RELEASE), GREAT BRITAIN | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENTS: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: KRESTOR, FILM-COATED TABLETS, 5 MG, 14 TABLETS IN A BLISTER; 2 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 5 MG ROSUVASTATIN AS 5.20 MG ROSUVASTATIN CALCIUM; MANUFACTURED BY IPIER PHARMACEUTICALS INC. (MANUFACTURER OF MEDICINE IN BULK), PUERTO RICO, USA/ ASTRAZENECA UK LIMITED (MANUFACTURER RESPONSIBLE FOR PACKAGING, CONTROL AND BATCH RELEASE), GREAT BRITAIN; KRESTOR, FILM-COATED TABLETS, 10 MG; 14 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 10 MG ROSUVASTATIN AS 10.40 MG ROSUVASTATIN CALCIUM; MANUFACTURED BY IPIER PHARMACEUTICALS INC. (MANUFACTURER OF IN BULK MEDICINE), PUERTO RICO, USA/ ASTRAZENECA UK LIMITED (MANUFACTURER RESPONSIBLE FOR PACKAGING, CONTROL AND BATCH RELEASE), GREAT BRITAIN; KRESTOR, FILM-COATED TABLETS, 20 MG; 14 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 20 MG ROSUVASTATIN AS 20.80 MG ROSUVASTATIN CALCIUM; MANUFACTURED BY IPIER PHARMACEUTICALS INC. (MANUFACTURER OF IN BULK MEDICINE), PUERTO RICO, USA/ ASTRAZENECA UK LIMITED (MANUFACTURER RESPONSIBLE FOR PACKAGING, CONTROL AND BATCH RELEASE), GREAT BRITAIN; KRESTOR, FILM-COATED TABLETS, 40 MG; 7 TABLETS IN BLISTERS; 4 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 40 MG ROSUVASTATIN AS 41.60 MG ROSUVASTATIN CALCIUM; MANUFACTURED BY IPIER PHARMACEUTICALS INC. (MANUFACTURER OF ""IN BULK"" DRUG), PUERTO RICO, USA/ ASTRAZENECA UK LIMITED (MANUFACTURER RESPONSIBLE FOR PACKAGING, CONTROL AND BATCH RELEASE), GREAT BRITAIN | |
|
PUERTO RICO | UKRAINE | 0 |
| 3004900000 | 1.LOES FOR PEOPLE, WITHOUT CONTENT: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: CASODEX, TABLETS COVERED WITH A FILM SHEATH, 50 MG, 14 TABLETS IN A BLISTER; 2 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINING 50 MG OF BICALUTAMIDE; MANUFACTURER CORDEN PHARMA GMBH (MANUFACTURER RESPONSIBLE FOR ""IN BULK"" PRODUCTION), GERMANY/ ASTRAZENECA UK LIMITED (MANUFACTURER RESPONSIBLE FOR PRIMARY AND SECONDARY PACKAGING, BATCH RELEASE), GREAT BRITAIN; CASODEX, FILM-COATED TABLETS, 150 MG, 14 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINING 150 MG OF BICALUTAMIDE; MANUFACTURER CORDEN PHARMA GMBH (RESPONSIBLE FOR ""IN BULK"" PRODUCTION), GERMANY/ ASTRAZENECA UK LIMITED (RESPONSIBLE FOR PRIMARY AND SECONDARY PACKAGING , SERIES ISSUE), GREAT BRITAIN | |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENTS: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: BETALOK, SOLUTION FOR INJECTION, 1 MG/ML; 5 ML IN AN AMPOULE; 5 AMPOULES IN A CARDBOARD BOX / 1 ML CONTAINS METOPROLOL TARTRATE 1 MG; MANUFACTURER SENEXI, FRANCE | |
|
FRANCE | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENT: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: CALQUENS, HARD CAPSULES, 100 MG, 6 HARD CAPSULES IN A BLISTER; 10 BLISTERS IN A CARDBOARD BOX / 1 HARD CAPSULE CONTAINS ACALABRUTINIB 100 MG; MANUFACTURER ASTRAZENECA AB (MANUFACTURING, QUALITY CONTROL, PRIMARY AND SECONDARY PACKAGING, SERIES RELEASE), SWEDEN | |
|
SWEDEN | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENTS: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: TAGRISSO, FILM-COATED TABLETS, 80 MG OF 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 80 MG OF OSIMERTINIB; MANUFACTURER ASTRAZENECA AB (MANUFACTURING, QUALITY CONTROL, SERIES RELEASE, PRIMARY AND SECONDARY PACKAGING), SWEDEN | |
|
SWEDEN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMAN USE, PACKAGED FOR RETAIL TRADE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. INJECTION, 250 MG/5 ML PO 5 ML SOLUTION IN PRE-FILLED GLASS SYRINGE WITH FIRST OPENING CONTROL; 2 PRE-FILLED SYRINGES EACH IN CONTOUR BLISTER PACK WITH TWO ""BD SAFETYGLIDE™"" SAFETY NEEDLES; PER 1 CONTOUR BLISTER IN A CARDBOARD BOX /1 PRE-FILLED SYRINGE (5 ML) CONTAINING FULVESTRAN 250 MG/VETTER PHARMA-FERTIGUN GMBH AND CO. KG (MANUFACTURING, PRIMARY PACKAGING, VISUAL CONTROL, BATCH TESTING; DESCRIPTION, IDENTIFICATION BY INFRARED SPECTROSCOPY, QUANTITATIVE DETERMINATION OF FULVESTRANTE BY HIGH PERFORMANCE LIQUID CHROMATOGRAPH (TOP), DEGRADATION PRODUCTS BY THE TOP METHOD, VOLUME OF SOLUTION FOR INJECTIONS IN CONTAINERS, FUNCTIONAL TESTING PFS, BACTERIAL ENDOTOXINS, MECHANICAL INCLUSIONS (INVISIBLE PARTICLES), STERILITY, ETHANOL CONTENT BY GAS CHROMATOGRAPHY (GC), BENZYL ALCOHOL CONTENT BY GC, BENZYL BENZOATE CONTENT BY GC; VISUAL CONTROL; VISUAL CONTROL, BATCH TESTING (STERILITY TESTING); PRODUCTION , PRIMARY PACKAGING, VISUAL INSPECTION, BATCH TESTING, DESCRIPTION, IDENTIFICATION BY INFRARED SPECTROSCOPY, QUANTITATION OF FULVESTRAN BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC), PRODUCT TE DEGRADATION BY TOP METHOD, VOLUME OF SOLUTION FOR INJECTION IN CONTAINERS, FUNCTIONAL TEST PFS , BACTERIAL ENDOTOXINS, MECHANICAL INCLUSIONS (INVISIBLE PARTICLES), STERILITY, ETHANOL CONTENT BY GAS CHROMATOGRAPHY (GC), BENZYL ALCOHOL CONTENT BY GC, BENZYLBENZOATE CONTENT BY GC), GERMANY ASTRAZENEKA YUK MITED (SECONDARY PACKAGING, BATCH RELEASE, STABILITY TESTING), UK | |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. MEDICINE FOR HUMANS, WITHOUT VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: SEROQUEL XR, FILM-COATED TABLETS, PROLONGED-RELEASE, 200 MG EACH 0 TABLETS IN BLISTERS; 6 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS 230.26 MG QUETIAPINE FUMARATE, EQUIVALENT TO 200 MG QUETIAPINE; MANUFACTURER ASTRAZENECA UK LIMITED (MANUFACTURER RESPONSIBLE FOR PACKAGING AND BATCH RELEASE), GREAT BRITAIN/ASTRAZENECA PHARMACEUTICALS LP (MANUFACTURER IN BULK), USA | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENT: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: LINPARZA, FILM-COATED TABLETS, 150 MG EACH; 8 TABLETS IN BLISTERS, 7 BLISTERS IN CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 150 MG OLAPARIB; MANUFACTURER ASTRAZENECA UK LIMITED (PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL, BATCH RELEASE), GREAT BRITAIN;ABVIE LIMITED (MANUFACTURING OF OLAPARIB TABLETS (EXTRUDED INTERMEDIATE AND POST-EXTRUSION STAGE) MANUFACTURING STAGE), QUALITY CONTROL), UNITED STATES OF AMERICA; ASTRAZENECA AB (MANUFACTURING OLAPARIBU TABLET (EXTRUDED INTERMEDIATE AND POST-EXTRUSION PRODUCTION STAGE), PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL, BATCH RELEASE, SWEDEN; LINPARZA, FILM-COATED TABLETS PO 100 MG; 8 TABLETS IN BLISTERS, 7 BLISTERS IN CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINING 100 MG OF OLAPARIB; MANUFACTURER ASTRAZENECA UK LIMITED (PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL, RELEASE SERIES), GREAT BRITAIN; ABBVI LIMITED (MANUFACTURER OF TABLETS OLAPARIBU (EXTRUDED INTERMEDIATE PRODUCTION STAGE AND POST-EXTRUSION PRODUCTION STAGE), QUALITY CONTROL, UNITED STATES OF AMERICA; ASTRAZENECA AB (OLAPARIBU TABLET MANUFACTURER (EXTRUDED INTERMEDIATE PRODUCTION STAGE) AND POST-EXTRUSION STAGE OF PRODUCTION), PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL, SERIES RELEASE) , SWEDEN | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENTS: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: LINPARZA, FILM-COATED TABLETS, 150 MG EACH; 8 TABLETS IN BLISTERS, 7 BLISTERS IN CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 150 MG OLAPARIB; MANUFACTURER ASTRAZENECA UK LIMITED (PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL, BATCH RELEASE), GREAT BRITAIN/ABVIE LIMITED (MANUFACTURING OF OLAPARIB TABLETS (EXTRUDED INTERMEDIATE AND POST-EXTRUSION STAGE) MANUFACTURING STAGE), QUALITY CONTROL), UNITED STATES OF AMERICA/ASTRAZENECA AB (MANUFACTURING OLAPARIB TABLET (EXTRUDED INTERMEDIATE AND POST-EXTRUSION PRODUCTION STAGE), PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL, BATCH RELEASE), SWEDEN | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMAN USE, PACKAGED FOR RETAIL TRADE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. LINPARZA TABLET KI, COVERED WITH A FILM COVER, 150 MG EACH; 8 TABLETS IN A BLISTER, 7 BLISTER IN A CARDBOARD BOX/1 FILM-COATED TABLET CONTAINING 150 MG OLAPARIB/ASTRAZENECA UK LIMITED (PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL (FINISHED MEDICINE). TOOL), SERIES ISSUE), GREAT BRITAIN ABBVI LIMITED ( OLAPARIB TABLET MANUFACTURING (EXTRUDED INTERMEDIATE AND POST-EXTRUSION PRODUCTION STAGE), QUALITY CONTROL (UNPACKED DRUG)) UNITED STATES OF AMERICA | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. MEDICINES FOR HUMANS, WITHOUT THE CONTENT OF: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: BETALOK ZOK, TABLETS COVERED WITH A FILM SHELL, WITH A DELAYED RELEASE OF 100 MG, 30 TABLETS IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX / 1 TABLET CONTAINS: 95 MG OF METOPROLOL SUCCINATE, WHICH CORRESPONDS TO 100 MG OF METOPROLOL TARTRATE; MANUFACTURER ASTRAZENECA AB, SWEDEN; BRILINTA, FILM-COATED TABLETS, 60 MG EACH; 14 TABLETS IN A BLISTER; 4 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 60 MG OF TICAGRELOR; MANUFACTURER ASTRAZENECA AB, SWEDEN; | |
|
SWEDEN | UKRAINE | 0 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Why should you choose Eximpedia?
Broad Range of Country Datasets
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
Easy to understand deep analysis
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
Most Accurate Information
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Competitive Supplier Engagement Watch
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
Right away on-screen support
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Access Database Across 130+ Countries
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
Astrazeneca Ab frequently asked questions
You can explore detailed shipment records of Astrazeneca Ab through Eximpedia’s real-time trade insights platform, which provides access to shipment dates, quantities, ports, and product details.
Yes, Eximpedia offers a directory of buyers with similar trade patterns to Astrazeneca Ab. Use advanced filters to identify competitors or partners in the same industry.
With our data-driven platform, you can access a curated list of suppliers with comparable product categories and shipment volumes to Astrazeneca Ab, helping you expand your sourcing network.
Eximpedia’s trade data highlights Astrazeneca Ab’s major exports, along with their trade destinations and origins.
We provide detailed analytics, including trade volumes, market trends, port usage, and competitor insights, to help businesses understand Astrazeneca Ab’s trade activities.
Traders can collaborate with Astrazeneca Ab by contacting them through their official channels or visiting their headquarters for detailed trade discussions.